Literature DB >> 31411629

Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals.

Yuichiro Yano1, Rikki M Tanner2, Swati Sakhuja2, Byron C Jaeger3, John N Booth2, Marwah Abdalla4, Daniel Pugliese4, Samantha R Seals5, Gbenga Ogedegbe6, Daniel W Jones7, Paul Muntner2, Daichi Shimbo4.   

Abstract

Importance: Little is known regarding health outcomes associated with higher blood pressure (BP) levels measured outside the clinic among African American individuals. Objective: To examine whether daytime and nighttime BP levels measured outside the clinic among African American individuals are associated with cardiovascular disease (CVD) and all-cause mortality independent of BP levels measured inside the clinic. Design, Setting, and Participants: This prospective cohort study analyzed data from 1034 African American participants in the Jackson Heart Study who completed ambulatory BP monitoring at baseline (September 26, 2000, to March 31, 2004). Mean daytime and nighttime BPs were calculated based on measurements taken while participants were awake and asleep, respectively. Data were analyzed from July 1, 2017, to April 30, 2019. Main Outcomes and Measures: Cardiovascular disease events, including coronary heart disease and stroke, experienced through December 31, 2014, and all-cause mortality experienced through December 31, 2016, were adjudicated. The associations of daytime BP and nighttime BP, separately, with CVD events and all-cause mortality were determined using Cox proportional hazards regression models.
Results: A total of 1034 participants (mean [SD] age, 58.9 [10.9] years; 337 [32.6%] male; and 583 [56.4%] taking antihypertensive medication) were included in the study. The mean daytime systolic BP (SBP)/diastolic BP (DBP) was 129.4/77.6 mm Hg, and the mean nighttime SBP/DBP was 121.3/68.4 mm Hg. During follow-up (median [interquartile range], 12.5 [11.1-13.6] years for CVD and 14.8 [13.7-15.6] years for all-cause mortality), 113 CVD events and 194 deaths occurred. After multivariable adjustment, including in-clinic SBP and DBP, the hazard ratios (HRs) for CVD events for each SD higher level were 1.53 (95% CI, 1.24-1.88) for daytime SBP (per 13.5 mm Hg), 1.48 (95% CI, 1.22-1.80) for nighttime SBP (per 15.5 mm Hg), 1.25 (95% CI, 1.02-1.51) for daytime DBP (per 9.3 mm Hg), and 1.30 (95% CI, 1.06-1.59) for nighttime DBP (per 9.5 mm Hg). Nighttime SBP was associated with all-cause mortality (HR per 1-SD higher level, 1.24; 95% CI, 1.06-1.45), but no association was present for daytime SBP (HR, 1.13; 95% CI, 0.97-1.33) and daytime (HR, 0.95; 95% CI, 0.81-1.10) and nighttime (HR, 1.06; 95% CI, 0.90-1.24) DBP. Conclusions and Relevance: Among African American individuals, higher daytime and nighttime SBPs were associated with an increased risk for CVD events and all-cause mortality independent of BP levels measured in the clinic. Measurement of daytime and nighttime BP using ambulatory monitoring during a 24-hour period may help identify African American individuals who have an increased cardiovascular disease risk.

Entities:  

Mesh:

Year:  2019        PMID: 31411629      PMCID: PMC6694386          DOI: 10.1001/jamacardio.2019.2845

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  34 in total

1.  Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.

Authors:  John N Booth; Keith M Diaz; Samantha R Seals; Mario Sims; Joseph Ravenell; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

2.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

3.  Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.

Authors:  Joseph Ravenell; Daichi Shimbo; John N Booth; Daniel F Sarpong; Charles Agyemang; Danielle L Beatty Moody; Marwah Abdalla; Tanya M Spruill; Amanda J Shallcross; Adam P Bress; Paul Muntner; Gbenga Ogedegbe
Journal:  Circulation       Date:  2017-04-20       Impact factor: 29.690

Review 4.  Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension.

Authors:  George C Roush; Robert H Fagard; Gil F Salles; Sante D Pierdomenico; Gianpaolo Reboldi; Paolo Verdecchia; Kazuo Eguchi; Kazuomi Kario; Satoshi Hoshide; Jorge Polonia; Alejandro de la Sierra; Ramon C Hermida; Eamon Dolan; Hernan Zamalloa
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

5.  Calibration of blood pressure measurements in the Jackson Heart Study.

Authors:  Samantha R Seals; Lisandro D Colantonio; Jonathan V Tingle; Daichi Shimbo; Adolfo Correa; Michael E Griswold; Paul Muntner
Journal:  Blood Press Monit       Date:  2019-06       Impact factor: 1.444

6.  Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.

Authors:  Shia T Kent; Daichi Shimbo; Lei Huang; Keith M Diaz; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2014-10-02

7.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

8.  Evaluating different criteria for defining a complete ambulatory blood pressure monitoring recording: data from the Jackson Heart Study.

Authors:  Samantha G Bromfield; John N Booth; Matthew S Loop; Joseph E Schwartz; Samantha R Seals; Stephen J Thomas; Yuan-I Min; Gbenga Ogedegbe; Daichi Shimbo; Paul Muntner
Journal:  Blood Press Monit       Date:  2018-04       Impact factor: 1.444

9.  Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Paul Muntner; Cora E Lewis; Keith M Diaz; April P Carson; Yongin Kim; David Calhoun; Yuichiro Yano; Anthony J Viera; Daichi Shimbo
Journal:  Am J Hypertens       Date:  2014-11-04       Impact factor: 3.080

Review 10.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

View more
  12 in total

1.  Error in the Figure.

Authors: 
Journal:  JAMA Cardiol       Date:  2019-09-01       Impact factor: 14.676

2.  Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.

Authors:  Qihong Wu; Mona Hong; Jianzhong Xu; Xiaofeng Tang; Limin Zhu; Pingjin Gao; Jiguang Wang
Journal:  Endocrine       Date:  2021-01-21       Impact factor: 3.633

3.  Impact of Asleep and 24-Hour Blood Pressure Data on the Prevalence of Masked Hypertension by Race/Ethnicity.

Authors:  Yuichiro Yano; Bharat Poudel; Ligong Chen; Swati Sakhuja; Byron C Jaeger; Anthony J Viera; Daichi Shimbo; Donald Clark; David Edmund Anstey; Feng-Chang Lin; Cora E Lewis; James M Shikany; Jamal S Rana; Adolfo Correa; Donald M Lloyd-Jones; Joseph E Schwartz; Paul Muntner
Journal:  Am J Hypertens       Date:  2022-07-01       Impact factor: 3.080

4.  Number and timing of ambulatory blood pressure monitoring measurements.

Authors:  Byron C Jaeger; Oluwasegun P Akinyelure; Swati Sakhuja; Joshua D Bundy; Cora E Lewis; Yuichiro Yano; George Howard; Daichi Shimbo; Paul Muntner; Joseph E Schwartz
Journal:  Hypertens Res       Date:  2021-08-11       Impact factor: 5.528

Review 5.  Team Science: American Heart Association's Hypertension Strategically Focused Research Network Experience.

Authors:  Mark K Santillan; Richard C Becker; David A Calhoun; Allen W Cowley; Joseph T Flynn; Justin L Grobe; Theodore A Kotchen; Daniel T Lackland; Kimberly K Leslie; Mingyu Liang; David L Mattson; Kevin E Meyers; Mark M Mitsnefes; Paul M Muntner; Gary L Pierce; Jennifer S Pollock; Curt D Sigmund; Stephen J Thomas; Elaine M Urbina; Srividya Kidambi
Journal:  Hypertension       Date:  2021-05-03       Impact factor: 9.897

6.  Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.

Authors:  Joshua J Joseph; Neal K Pohlman; Songzhu Zhao; David Kline; Guy Brock; Justin B Echouffo-Tcheugui; Mario Sims; Valery S Effoe; Wen-Chih Wu; Rita R Kalyani; Gary S Wand; Bjorn Kluwe; Willa A Hsueh; Marwah Abdalla; Daichi Shimbo; Sherita H Golden
Journal:  Circulation       Date:  2021-02-19       Impact factor: 39.918

7.  Twenty-four-hour versus clinic blood pressure levels as predictors of long-term cardiovascular and renal disease outcomes among African Americans.

Authors:  Srividya Kidambi; Tao Wang; Thomas Chelius; Irene Nunuk; Priyanka Agarwal; Purushottam Laud; David Mattson; Allen W Cowley; Mingyu Liang; Theodore Kotchen
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

8.  Cinnamon effects on blood pressure and metabolic profile: A double-blind, randomized, placebo-controlled trial in patients with stage 1 hypertension.

Authors:  Fatemeh Shirzad; Negar Morovatdar; Ramin Rezaee; Konstantinos Tsarouhas; Alireza Abdollahi Moghadam
Journal:  Avicenna J Phytomed       Date:  2021 Jan-Feb

9.  Twenty-Five-Year Changes in Office and Ambulatory Blood Pressure: Results From the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Joshua D Bundy; Byron C Jaeger; Mark D Huffman; Sarah S Knox; S Justin Thomas; Daichi Shimbo; John N Booth; Cora E Lewis; Lloyd J Edwards; Joseph E Schwartz; Paul Muntner
Journal:  Am J Hypertens       Date:  2021-05-22       Impact factor: 3.080

10.  Using Predicted Atherosclerotic Cardiovascular Disease Risk for Discrimination of Awake or Nocturnal Hypertension.

Authors:  Swati Sakhuja; John N Booth; David E Anstey; Byron C Jaeger; Cora E Lewis; Donald M Lloyd-Jones; Joseph E Schwartz; Daichi Shimbo; James M Shikany; Mario Sims; Paul Muntner
Journal:  Am J Hypertens       Date:  2020-11-03       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.